膜层析法市场 - 全球产业规模、份额、趋势、机会及预测（按产品、技术、最终用途、地区和竞争格局划分，2021-2031年）

全球膜层析法市场预计将从 2025 年的 3.9319 亿美元成长到 2031 年的 8.7262 亿美元，复合年增长率达到 14.21%。

这项技术利用配备特定配体的微孔膜，根据目标分子（例如蛋白质和抗体）的特定化学性质，选择性地分离它们。该市场的成长主要受全球对生物製药日益增长的需求以及为消除纯化瓶颈而对高通量下游加工的需求所驱动。此外，这些膜技术无需清洗验证，缩短了周转时间，正在推动产业向一次性生产设施转型，并加速其应用。欧洲製药工业协会联合会 (EFPIA) 的报告显示，生物製造技术的进步带来了显着的规模经济效益，预计到 2024 年，欧洲以研发为基础的製药业将在研发方面投入约 550 亿欧元。

儘管存在这些成长要素，但由于薄膜的结合能力远低于传统层析法树脂，市场仍面临巨大的障碍。膜吸附剂在流通式纯化步骤中表现出色，但其较低的表面积限制了其在大规模捕集应用中的有效性，而高结合能力对于成本效益至关重要。这项技术限制迫使製造商继续使用传统的填充床层析法法处理高浓度进料流，从而阻碍了树脂基方法的完全替代，并减缓了膜层析法在所有纯化步骤中的更广泛应用。

市场驱动因素

全球膜层析法市场的主要驱动力是病毒载体和基因治疗药物生产的扩张。与标准单株抗体不同，慢病毒和腺相关病毒（AAV）等病毒载体是大分子，在传统的树脂基介质中扩散缓慢，导致下游加工环节出现显着瓶颈。膜吸附装置利用对流解决了这个问题，即使对于这些大分子构建体也能保持高通量和高结合能力，有效满足了产业可扩展的纯化需求。如此活跃的研发管线催生了对这些专用技术的迫切需求。根据再生医学联盟2024年1月发布的《产业趋势简报》，美国和欧洲监管机构预计在2024年对多达17种新型细胞和基因疗法做出审批决定，凸显了推动该领域发展的商业性压力。

同时，一次性生物製程技术的广泛应用正在加速向膜分离解决方案的转型。膜层析法装置通常以一次性胶囊的形式製造，完美契合了诸如无需清洁验证和防止多产品生产设施中的交叉污染等操作需求。这种相容性使製造商能够最大限度地减少资本投资的相互依赖性和设施占地面积，从而在竞争激烈的市场环境中获得关键优势。业界对一次性工具的依赖程度如此之高，以至于根据赛多利斯公司于2024年2月发布的2023年度报告，其生物工艺解决方案部门（一次性技术的领导者）的销售额达到了27亿欧元。此外，默克集团在2024年报告称，其生命科学部门在上年度的净销售额达到了93亿欧元，凸显了支持这些创新的供应链经济效益。

市场挑战

与传统填料树脂相比，膜吸附剂的低结合容量是限制全球膜层析法市场成长的一大阻碍因素。这项技术缺陷限制了薄膜在生物製药生产回收阶段的应用，而该阶段需要高结合容量才能有效处理大量产品。在处理高浓度进料流时，薄膜会迅速饱和，导致製造商无法将其应用于大规模捕集工艺，其应用主要局限于流通式纯化。因此，该技术无法成为商业生产中传统方法的全面替代方案，其获利潜力也仅限于某些下游製程。

鑑于越来越多的大分子药物进入开发平臺，无法支持高效价捕获尤其具有限制。根据美国药品研究与製造商协会（PhRMA）预测，到2024年，全球将有超过8,000种药物处于研发阶段，其中许多是复杂的生物製药，需要先进的下游加工流程。目前，膜技术无法经济有效地满足这些高需求治疗药物的大规模捕获需求，因此生物製药生产商仍然依赖树脂柱。这种对传统初级纯化技术的依赖阻碍了膜层析法在生产流程中更广泛的应用。

市场趋势

製造商正加速将膜吸附装置整合到连续下游生产线中，利用其在高流速下运作且不受填充床压降限制的优势。这种整合实现了稳态纯化，显着减少了设备面积和缓衝液消耗，同时提高了整体製程经济性。大型合约研发生产企业（CDMO）不断扩展其连续加工能力，展现出的商业性韧性，证明了这种转变的有效性。例如，药明生物在2024年8月发布的「2024财年中期财务业绩」中报告称，上半年新增了61个整合客户计划，这一增长势头得益于其自主研发的药明UP连续加工平台的推出。

同时，市场正经历数位转型，新型系统融合了人工智慧和先进的感测器技术，用于优化层析法循环并预测膜堵塞。这些智慧工具能够实现即时放行侦测和即时製程监控，确保产品品质稳定，同时最大限度地降低代价高昂的批次失败风险。这种对数位化基础设施的优先发展正在重塑整个产业的财务策略。正如罗克韦尔自动化公司在2024年8月发布的《智慧製造报告：生命科学》中所指出的，技术投资将飙升至营运预算的31%，目前96%的生命科学製造商正在使用或评估智慧製造技术以提高营运效率。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球膜层析法市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 副产品（胶囊、盒式过滤器、滤芯、注射器过滤器、薄膜过滤器、滤板、离心柱等）
  • 依技术（离子交换膜层析法、亲和性和膜层析法、疏水交互作用膜层析法）
  • 依最终用途（製药/生技公司、CRO/CMO、学术研究机构）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美膜层析法市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲膜层析法市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区膜层析法市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲膜层析法市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美洲膜层析法市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球膜层析法市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• 3M Company
• Asahi Kasei Corporation
• Danaher Corporation
• Merck KGaA
• Cole-Parmer Instrument Company, LLC
• Thermo Fisher Scientific Inc.
• Sartorius AG
• Air Products and Chemicals, Inc.
• Purilogics, LLC
• Restek Corporation

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Membrane Chromatography Market is projected to expand from USD 393.19 Million in 2025 to USD 872.62 Million by 2031, achieving a CAGR of 14.21%. This technology employs microporous membranes outfitted with specific ligands to selectively isolate target molecules, such as proteins and antibodies, based on their chemical characteristics. The market is primarily propelled by the escalating global demand for biopharmaceuticals and the necessity for high-throughput downstream processing to alleviate purification bottlenecks. Furthermore, the industry's transition toward single-use manufacturing facilities supports adoption, as these membranes negate cleaning validation requirements and speed up turnaround times. Highlighting the financial scale of these biomanufacturing advancements, the European Federation of Pharmaceutical Industries and Associations reported that the research-based pharmaceutical industry invested approximately €55,000 million in R&D across Europe in 2024.

Despite these growth drivers, the market encounters a substantial obstacle due to the limited binding capacity of membranes relative to traditional chromatography resins. Although membrane adsorbers perform exceptionally well in flow-through polishing phases, their reduced surface area restricts their effectiveness in large-scale capture applications where high binding capacity is crucial for cost efficiency. This technical constraint compels manufacturers to persist with traditional packed-bed chromatography for high-concentration feed streams, thereby preventing the total replacement of resin-based methods and slowing the wider expansion of membrane chromatography across all purification steps.

Market Driver

A major catalyst driving the Global Membrane Chromatography Market is the expansion of viral vector and gene therapy manufacturing. Unlike standard monoclonal antibodies, viral vectors like Lentivirus and AAV are large macromolecules that experience slow diffusion rates in traditional resin-based media, causing significant downstream processing bottlenecks. Membrane adsorbers resolve this by employing convective flow, which maintains high processing speeds and binding capacities even for these large structures, effectively meeting the industry's need for scalable purification. This intense pipeline activity is generating urgent demand for such specialized technologies; according to the Alliance for Regenerative Medicine's January 2024 "State of the Industry Briefing," regulatory bodies in the US and Europe were anticipated to issue decisions on up to 17 new cell and gene therapies in 2024, underscoring the commercial pressure fueling the sector.

concurrently, the widespread integration of single-use bioprocessing technologies is accelerating the transition toward membrane-based solutions. Membrane chromatography units are typically produced as disposable capsules, which aligns perfectly with operational needs to eliminate cleaning validation and prevent cross-contamination in multi-product facilities. This compatibility permits manufacturers to minimize capital interaction and facility footprint, a vital advantage in the competitive contract manufacturing landscape. The scale of industrial reliance on disposable tools is significant; according to Sartorius's "Annual Report 2023" published in February 2024, their Bioprocess Solutions division, a leader in single-use technologies, achieved €2.7 billion in sales revenue. Additionally, Merck KGaA reported in 2024 that its Life Science business sector generated €9.3 billion in net sales during the prior fiscal year, highlighting the economic magnitude of the supply chain supporting these advancements.

Market Challenge

The lower binding capacity of membrane adsorbers compared to conventional packed-bed resins represents a significant restraint on the global membrane chromatography market's growth. This technical deficiency limits the utility of membranes during the capture phase of biopharmaceutical manufacturing, where high binding capabilities are required to process large product volumes efficiently. Since membranes saturate rapidly when handling high-concentration feed streams, manufacturers are unable to employ them for large-scale capture steps, restricting their application primarily to flow-through polishing. Consequently, this prevents the technology from serving as a comprehensive substitute for traditional methods in commercial production and limits its revenue potential to specific downstream stages.

The inability to support high-titer capture is particularly restrictive given the increasing volume of large-molecule drugs entering the development pipeline. According to the Pharmaceutical Research and Manufacturers of America, there were over 8,000 medicines in development globally in 2024, many of which are complex biologics requiring intensive downstream processing. Because membranes cannot currently manage the bulk capture requirements for these high-demand therapies in a cost-effective manner, biomanufacturers continue to depend on resin-based columns. This reliance on legacy technology for primary purification prevents membrane chromatography from achieving broader adoption across the full manufacturing workflow.

Market Trends

Manufacturers are increasingly integrating membrane adsorbers into continuous downstream processing lines, utilizing their ability to operate at high flow rates without the pressure drop limitations associated with packed beds. This integration enables steady-state purification, which significantly lowers facility footprint and buffer consumption while enhancing overall process economics. The validity of this shift is demonstrated by the commercial resilience of major CDMOs expanding their continuous capabilities; for instance, WuXi Biologics reported in their "2024 Interim Results" in August 2024 that the company added 61 new integrated client projects in the first half of the year, a growth trajectory supported by the deployment of their proprietary WuXiUP continuous processing platform.

Simultaneously, the market is experiencing a digital transformation as new systems incorporate artificial intelligence and advanced sensor technologies to optimize chromatography cycles and predict membrane fouling. These intelligent tools facilitate real-time release testing and instantaneous process monitoring, ensuring consistent product quality while minimizing the risk of costly batch failures. The prioritization of such digital infrastructure is reshaping financial strategies throughout the sector. As noted by Rockwell Automation in the "State of Smart Manufacturing Report: Life Sciences Edition" from August 2024, technology investments have surged to account for 31% of operating budgets, with 96% of life sciences manufacturers now utilizing or evaluating smart manufacturing technologies to improve operational efficiency.

Key Market Players

• 3M Company
• Asahi Kasei Corporation
• Danaher Corporation
• Merck KGaA
• Cole-Parmer Instrument Company, LLC
• Thermo Fisher Scientific Inc.
• Sartorius AG
• Air Products and Chemicals, Inc.
• Purilogics, LLC
• Restek Corporation

Report Scope

In this report, the Global Membrane Chromatography Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Membrane Chromatography Market, By Product

• Capsules Cassette & Cartridges
• Syringe Filters
• Membrane Filters
• Filter Plates
• Spin Columns
• and Others

Membrane Chromatography Market, By Technique

• Ion Exchange Membrane Chromatography
• Affinity Membrane Chromatography
• and Hydrophobic Interaction Membrane Chromatography

Membrane Chromatography Market, By End Use

• Pharmaceutical & Biotechnology Companies
• CRO & CMO
• and Academic Research Institutes

Membrane Chromatography Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Membrane Chromatography Market.

Available Customizations:

Global Membrane Chromatography Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Membrane Chromatography Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Capsules Cassette & Cartridges, Syringe Filters, Membrane Filters, Filter Plates, Spin Columns, and Others)
  • 5.2.2. By Technique (Ion Exchange Membrane Chromatography, Affinity Membrane Chromatography, and Hydrophobic Interaction Membrane Chromatography)
  • 5.2.3. By End Use (Pharmaceutical & Biotechnology Companies, CRO & CMO, and Academic Research Institutes)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Membrane Chromatography Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Technique
  • 6.2.3. By End Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Membrane Chromatography Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Technique
      • 6.3.1.2.3. By End Use
  • 6.3.2. Canada Membrane Chromatography Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Technique
      • 6.3.2.2.3. By End Use
  • 6.3.3. Mexico Membrane Chromatography Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Technique
      • 6.3.3.2.3. By End Use

7. Europe Membrane Chromatography Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Technique
  • 7.2.3. By End Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Membrane Chromatography Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Technique
      • 7.3.1.2.3. By End Use
  • 7.3.2. France Membrane Chromatography Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Technique
      • 7.3.2.2.3. By End Use
  • 7.3.3. United Kingdom Membrane Chromatography Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Technique
      • 7.3.3.2.3. By End Use
  • 7.3.4. Italy Membrane Chromatography Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Technique
      • 7.3.4.2.3. By End Use
  • 7.3.5. Spain Membrane Chromatography Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Technique
      • 7.3.5.2.3. By End Use

8. Asia Pacific Membrane Chromatography Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Technique
  • 8.2.3. By End Use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Membrane Chromatography Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Technique
      • 8.3.1.2.3. By End Use
  • 8.3.2. India Membrane Chromatography Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Technique
      • 8.3.2.2.3. By End Use
  • 8.3.3. Japan Membrane Chromatography Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Technique
      • 8.3.3.2.3. By End Use
  • 8.3.4. South Korea Membrane Chromatography Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Technique
      • 8.3.4.2.3. By End Use
  • 8.3.5. Australia Membrane Chromatography Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Technique
      • 8.3.5.2.3. By End Use

9. Middle East & Africa Membrane Chromatography Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Technique
  • 9.2.3. By End Use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Membrane Chromatography Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Technique
      • 9.3.1.2.3. By End Use
  • 9.3.2. UAE Membrane Chromatography Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Technique
      • 9.3.2.2.3. By End Use
  • 9.3.3. South Africa Membrane Chromatography Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Technique
      • 9.3.3.2.3. By End Use

10. South America Membrane Chromatography Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Technique
  • 10.2.3. By End Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Membrane Chromatography Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Technique
      • 10.3.1.2.3. By End Use
  • 10.3.2. Colombia Membrane Chromatography Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Technique
      • 10.3.2.2.3. By End Use
  • 10.3.3. Argentina Membrane Chromatography Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Technique
      • 10.3.3.2.3. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Membrane Chromatography Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. 3M Company
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Asahi Kasei Corporation
• 15.3. Danaher Corporation
• 15.4. Merck KGaA
• 15.5. Cole-Parmer Instrument Company, LLC
• 15.6. Thermo Fisher Scientific Inc.
• 15.7. Sartorius AG
• 15.8. Air Products and Chemicals, Inc.
• 15.9. Purilogics, LLC
• 15.10. Restek Corporation

16. Strategic Recommendations

17. About Us & Disclaimer